Literature DB >> 28236339

Mutations of the aminoacyl-tRNA-synthetases SARS and WARS2 are implicated in the etiology of autosomal recessive intellectual disability.

Luciana Musante1, Lucia Püttmann1, Kimia Kahrizi2, Masoud Garshasbi1, Hao Hu1, Henning Stehr3, Bettina Lipkowitz1, Sabine Otto1, Lars R Jensen4, Andreas Tzschach1, Payman Jamali5, Thomas Wienker1, Hossein Najmabadi2, Hans Hilger Ropers1, Andreas W Kuss4.   

Abstract

Intellectual disability (ID) is the hallmark of an extremely heterogeneous group of disorders that comprises a wide variety of syndromic and non-syndromic phenotypes. Here, we report on mutations in two aminoacyl-tRNA synthetases that are associated with ID in two unrelated Iranian families. In the first family, we identified a homozygous missense mutation (c.514G>A, p.Asp172Asn) in the cytoplasmic seryl-tRNA synthetase (SARS) gene. The mutation affects the enzymatic core domain of the protein and impairs its enzymatic activity, probably leading to reduced cytoplasmic tRNASer concentrations. The mutant protein was predicted to be unstable, which could be substantiated by investigating ectopic mutant SARS in transfected HEK293T cells. In the second family, we found a compound heterozygous genotype of the mitochondrial tryptophanyl-tRNA synthetase (WARS2) gene, comprising a nonsense mutation (c.325delA, p.Ser109Alafs*15), which very likely entails nonsense-mediated mRNA decay and a missense mutation (c.37T>G, p.Trp13Gly). The latter affects the mitochondrial localization signal of WARS2, causing protein mislocalization. Including AIMP1, which we have recently implicated in the etiology of ID, three genes with a role in tRNA-aminoacylation are now associated with this condition. We therefore suggest that the functional integrity of tRNAs in general is an important factor in the development and maintenance of human cognitive functions.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  SARS; WARS2; aminoacyl-tRNA-synthetase; aminoacylation; brain; cognition; intellectual disability; tRNA

Mesh:

Substances:

Year:  2017        PMID: 28236339     DOI: 10.1002/humu.23205

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  24 in total

Review 1.  Emerging mechanisms of aminoacyl-tRNA synthetase mutations in recessive and dominant human disease.

Authors:  Rebecca Meyer-Schuman; Anthony Antonellis
Journal:  Hum Mol Genet       Date:  2017-10-01       Impact factor: 6.150

2.  Pathogenic variants in AIMP1 cause pontocerebellar hypoplasia.

Authors:  Andrea Accogli; Laura Russell; Guillaume Sébire; Jean-Baptiste Rivière; Judith St-Onge; Nassima Addour-Boudrahem; Alexandre Dionne Laporte; Guy A Rouleau; Christine Saint-Martin; Myriam Srour
Journal:  Neurogenetics       Date:  2019-03-28       Impact factor: 2.660

Review 3.  Mitochondrial energy generation disorders: genes, mechanisms, and clues to pathology.

Authors:  Ann E Frazier; David R Thorburn; Alison G Compton
Journal:  J Biol Chem       Date:  2017-12-12       Impact factor: 5.157

4.  Mutation of the WARS2 Gene as the Cause of a Severe Hyperkinetic Movement Disorder.

Authors:  Annemarie Hübers; Hans-Jürgen Huppertz; Saskia B Wortmann; Jan Kassubek
Journal:  Mov Disord Clin Pract       Date:  2019-11-07

Review 5.  tRNA Metabolism and Neurodevelopmental Disorders.

Authors:  Ashleigh E Schaffer; Otis Pinkard; Jeffery M Coller
Journal:  Annu Rev Genomics Hum Genet       Date:  2019-05-13       Impact factor: 8.929

Review 6.  When a common biological role does not imply common disease outcomes: Disparate pathology linked to human mitochondrial aminoacyl-tRNA synthetases.

Authors:  Ligia Elena González-Serrano; Joseph W Chihade; Marie Sissler
Journal:  J Biol Chem       Date:  2019-01-15       Impact factor: 5.157

7.  Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.

Authors:  Joshi Stephen; Sheela Nampoothiri; Aditi Banerjee; Nathanial J Tolman; Josef Martin Penninger; Ullrich Elling; Chukwuma A Agu; John D Burke; Kalpana Devadathan; Rajesh Kannan; Yan Huang; Peter J Steinbach; Susan A Martinis; William A Gahl; May Christine V Malicdan
Journal:  Hum Genet       Date:  2018-04-24       Impact factor: 4.132

8.  New insights into the phenotype of FARS2 deficiency.

Authors:  Elise Vantroys; Austin Larson; Marisa Friederich; Kaz Knight; Michael A Swanson; Christopher A Powell; Joél Smet; Sarah Vergult; Boel De Paepe; Sara Seneca; Herbert Roeyers; Björn Menten; Michal Minczuk; Arnaud Vanlander; Johan Van Hove; Rudy Van Coster
Journal:  Mol Genet Metab       Date:  2017-10-12       Impact factor: 4.797

Review 9.  The role of tRNA synthetases in neurological and neuromuscular disorders.

Authors:  Veronika Boczonadi; Matthew J Jennings; Rita Horvath
Journal:  FEBS Lett       Date:  2018-02-01       Impact factor: 4.124

10.  Novel GFM2 variants associated with early-onset neurological presentations of mitochondrial disease and impaired expression of OXPHOS subunits.

Authors:  Ruth I C Glasgow; Kyle Thompson; Inês A Barbosa; Langping He; Charlotte L Alston; Charu Deshpande; Michael A Simpson; Andrew A M Morris; Axel Neu; Ulrike Löbel; Julie Hall; Holger Prokisch; Tobias B Haack; Maja Hempel; Robert McFarland; Robert W Taylor
Journal:  Neurogenetics       Date:  2017-10-26       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.